melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.400 |
None |
0.986 |
73 |
|
1994 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.982 |
56 |
|
1995 |
2019 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.100 |
None |
1.000 |
14 |
|
1992 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
10 |
|
1992 |
2015 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.100 |
None |
1.000 |
10 |
|
1998 |
2019 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.080 |
None |
1.000 |
8 |
|
1996 |
2015 |
Low Grade Squamous Intraepithelial Neoplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
94
|
2
|
0.080 |
None |
1.000 |
8 |
|
1998 |
2018 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.060 |
None |
1.000 |
6 |
|
1996 |
2005 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
395
|
249
|
0.050 |
None |
1.000 |
5 |
|
1998 |
2018 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.050 |
None |
1.000 |
5 |
1
|
2007 |
2019 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.050 |
None |
1.000 |
5 |
|
1998 |
2018 |
High-Grade Squamous Intraepithelial Lesions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
150
|
8
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2009 |
Human papilloma virus infection
|
disease |
Infections
|
Disease or Syndrome
|
429
|
42
|
0.040 |
None |
1.000 |
4 |
1
|
2004 |
2015 |
Malignant tumor of cervix
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1718
|
245
|
0.030 |
None |
1.000 |
3 |
1
|
2010 |
2019 |
Tumor Immunity
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
337
|
2
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2018 |
Hypopigmentation disorder
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
126
|
15
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2018 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2017 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.030 |
None |
1.000 |
3 |
1
|
2010 |
2019 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2015 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2015 |